Further, the company also intends to begin marketing its current portfolio biomarkers to research laboratories globally. Michael Cohen, president and CEO of National Stem Cell Holding, said: “Our
NanoLink streptavidin particles are particularly suited for high throughput robotic applications where high biotin loads must be removed or immobilized without the presence of an iron leachate. Leo
Under the terms of the new three-year agreement with Magnet Cooperative, effective May 8, 2008, Magnet will offer the full line of the company’s products including the iQ200
The Regenesis trial is a double-blind, randomized, placebo-controlled Phase IIb clinical trial for Stem Cell Therapeutics’s (SCT) lead program, NTx-265, for the treatment of acute ischemic stroke. The
Targeted Molecular Diagnostics’s (TMD) KRAS Mutation assay (DxS Diagnostics), utilizes SNP-based Real-Time PCR technology to identify seven of the most common KRAS mutations in DNA from frozen or
This action will further focus the company’s resources on its strategic, business and clinical development initiatives. The cost reductions associated with the reorganization will enable the company to
Under the terms of the agreement, HemCon will leverage Sangui’s technology platform to enhance and expand its product offerings for surgical and wound care. HemCon developed the chitosan-based
PLacental eXpanded cells (PLX) cells are Pluristem’s placental-derived mesenchymal stromal cells (MSCs) that have been expanded in the company’s proprietary PluriX 3-D bioreactor. Mice and rats each received
The investors shall also receive three-year warrants to purchase an aggregate of 1.25 million shares of the company’s common stock at an exercise price of $2.80 per share,
The new formulation is a swallowable tablet that combines immediate-release omeprazole, a proton pump inhibitor, with a mix of buffers. Santarus plans to undertake clinical and stability studies
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.